Mandate

Vinge advises Capio in connection with acquisition of Scanloc

September 01, 2016

Scanloc conducts operations relating to specialist care within eye disorders at clinics situated in Gothenburg and Kungsbacka. The company’s customers primarily consist of the Västra Götaland and Halland County Councils. Scanloc has 35 employees and will be part of Capio Medocular. Closing is scheduled for 30 September and is conditional upon the customary closing conditions from the salient public authorities.

Vinge’s team consisted of responsible partner Anders Strid together with, among others, Frida Bäckergren (project manager), Frida Mattsson (employment), Victor Ericsson (tax) and Gabriella Fossum (public procurement).

Related

Vinge has advised Hansa Biopharma in connection with entering into a financing agreement

Vinge has advised Hansa Biopharma AB (publ), a commercial-stage biopharmaceutical company on a mission to develop and commercialize innovative, lifesaving and life-altering treatments for patients with rare immunological conditions, listed on Nasdaq Stockholm, in connection with a U.S. convertible note purchase agreement comprising USD 30 million aggregate principal amount of unsecured convertible senior notes.
March 23, 2026

Vinge advises in connection with data center provider EcoDataCenter’s tap issue of SEK 500 million bonds

Vinge has advised in connection with EcoDC Holding AB (publ)'s tap issue of SEK 500 million senior unsecured bonds under the existing framework of up to SEK 2 billion.
March 19, 2026

Vinge has advised Cinclus Pharma in connection with entering into financing agreement

Vinge has advised Cinclus Pharma Holding AB (publ), a late-stage clinical pharmaceutical company developing next-generation treatments for gastric acid-related diseases listed on Nasdaq Stockholm, in connection with a long-term structured credit agreement for a total of up to EUR 28 million divided into four tranches, of which two are convertibles.
March 16, 2026